News

16/05/2025

Review Highlights Cutting-Edge Cancer Therapies Targeting CXCR4

Researchers from the Sant Pau Research Institute (IR Sant Pau) and CIBER-BBN have led an exhaustive scientific review of therapies aimed at the CXCR4 receptor, a key target in more than 20 types of ca...

15/05/2025

IR Sant Pau Leads New Basic and Translational Research Network on Synaptic Circuits and Nervous System Diseases in Spain

The Sant Pau Research Institute (IR Sant Pau) has secured funding for the creation of the Network for the Integrative Study of Synaptic Circuits and Their Role in Disease. This network will be coordin...

15/05/2025

Letter in The Lancet Celebrates Arrival of Lecanemab as Start of Paradigm Shift in Europe, Questions EMA’s Veto of Donanemab

A recently published letter in The Lancet, signed by Dr. Juan Fortea and leading European experts in Alzheimer’s disease, celebrates the European Commission’s approval of lecanemab as a key milest...

14/05/2025

An Experimental Immunotherapy Reverses Heart Energy Damage Caused by Cholesterol

An international team of researchers has discovered how cholesterol can disrupt the internal functioning of the heart by accumulating in the mitochondria of cardiomyocytes. They have also developed an...

13/05/2025

The Sant Pau Research Institute Presents its New Strategic Plan 2025-2030

The Sant Pau Research Institute (IR Sant Pau) presented its new Strategic Plan 2025-2030 this Tuesday, in an event open to all research and healthcare staff. The plan will define the...